Vertex to Announce Second Quarter 2018 Financial Results on July 25
July 12 2018 - 3:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its second quarter 2018 financial results on Wednesday, July 25,
2018 after the financial markets close. The company will host a
conference call and webcast at 4:30 p.m. ET. To access the call,
please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001
(International).
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious and life-threatening diseases. In addition to clinical
development programs in CF, Vertex has more than a dozen ongoing
research programs focused on the underlying mechanisms of other
serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is
now located in Boston's Innovation District. Today, the company has
research and development sites and commercial offices in the United
States, Europe, Canada and Australia. Vertex is consistently
recognized as one of the industry's top places to work, including
being named to Science magazine's Top Employers in the life
sciences ranking for eight years in a row.
For additional information and the latest updates from the
company, please visit www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180712005816/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orEric Rojas, 617-961-7205orZach Barber,
617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From May 2023 to May 2024